Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 8.2B | 8.6B | 7.8B | 8.8B |
Cost of revenue | 7.2B | 7.7B | 6.9B | 8.7B |
Gross profit | 936M | 916M | 965M | 154M |
Operating expense | ||||
Research & development | 65M | 62M | 55M | 76M |
Selling general and admin | 968M | 1.1B | 962M | 1.1B |
Other operating expenses | 36M | — | 46M | 29M |
Operating income | -133M | -205M | -98M | -1.0B |
Non operating interest income | ||||
Income | 340M | 170M | 258M | -385M |
Expense | 357M | 162M | 278M | -342M |
Other income expense | — | — | — | — |
Pretax income | -53M | 267M | 20M | -983M |
Tax provision | 202M | 101M | 53M | 57M |
Net income | -255M | 167M | -33M | -1.0B |
Basic EPS | -0.5 | 0.3 | -0.1 | — |
Diluted EPS | -0.5 | 0.3 | -0.1 | — |
Basic average shares | 622.5M | 622.5M | 622.5M | — |
Diluted average shares | 622.5M | 622.5M | 622.5M | — |
EBITDA | 575M | 708M | 590M | -234M |
Net income from continuing op. | -255M | 167M | -33M | -1.0B |
Minority interests | -23M | -11M | -18M | -21M |
Preferred stock dividends | 0 | 0 | 0 | 0 |